Medical Review

Published by De Gruyter

Open access · CC BY · In DOAJ · People's Republic of China · Academic Publishing and Open Access

Journal at a glance

ISSN

2749-9642

Publisher

De Gruyter

Country

People's Republic of China

Language

en

License

CC BY

Also known as: Med Rev (2021) (Abbreviation), Medical review (2021) (Alternate title), Yixue pinglun (Alternate title)

Indexing

• DOAJ: Active
• Pubmed: Active

Metrics

Subjects

• Academic Publishing and Open Access
• Medical Research and Practices
• Meta-analysis and systematic reviews
• Nanoplatforms for cancer theranostics
• Immune cells in cancer
• Nanoparticle-Based Drug Delivery
• Cancer Immunotherapy and Biomarkers
• Medicine

Articles on PubPorta

The most recent records PubPorta holds for this journal.

• Artificial intelligence-based software as a medical device: regulatory evolution toward continuous oversight (2026)
• Biomarkers for risk stratification of malignancy-prone precancerous conditions: focusing on gastric intestinal metaplasia (2026)
• Radiotherapy, inflammation, and the myeloid perspective (2026)
• The Huchang-Barrier framework: an integrative perspective on the spatial features of the tumor invasive front (2026)
• Evolution of malignant tumors as neoorgan and predictions of future scenarios resulting from inappropriate treatment (2026)

Similar journals

• Journal of Applied Biomedicine — Czech Republic · Open access · Same subject: Academic Publishing and Open Access, Same subject: Medical Research and Practices, 3 shared subjects in total
• MedComm — People's Republic of China · Open access · Same subject: Cancer Immunotherapy and Biomarkers, Same subject: Immune cells in cancer, Same country
• ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES — People's Republic of China · Open access · Same subject: Nanoparticle-Based Drug Delivery, Same subject: Nanoplatforms for cancer theranostics, Same country
• Cancer Biology & Medicine — People's Republic of China · Open access · Same subject: Cancer Immunotherapy and Biomarkers, Same subject: Immune cells in cancer, Same country
• Frontiers in Immunology — Switzerland · Open access · Same subject: Cancer Immunotherapy and Biomarkers, Same subject: Immune cells in cancer
• Journal of Translational Medicine — United Kingdom · Open access · Same subject: Cancer Immunotherapy and Biomarkers, Same subject: Immune cells in cancer

Sources: DOAJ, OpenAlex, NLM Catalog, Crossref · Last verified 2026-09-05

Author guidelines